Skip to content Outputs by Type Journal article
2026
Targeting Peptidylarginine Deiminases in Neurons and Astrocytes in Central Nervous System Injury—Effects of Pan-PAD Inhibitor Cl-Amidine in an Oxygen–Glucose Deprivation Model of Ischaemia (OGD/R) and LPS Stimulation In Vitro Ahmed, D., Getting, S., Ashioti, M. and Lange, S. 2026. Targeting Peptidylarginine Deiminases in Neurons and Astrocytes in Central Nervous System Injury—Effects of Pan-PAD Inhibitor Cl-Amidine in an Oxygen–Glucose Deprivation Model of Ischaemia (OGD/R) and LPS Stimulation In Vitro. International Journal of Molecular Sciences. 27 (11) 5118. https://doi.org/10.3390/ijms27115118
2020
Late changes in blood-brain barrier permeability in a rat tMCAO model of stroke detected by gadolinium-enhanced MRI Morgan, C.A., Mesquita, M., Ashioti, M., Beech, J.S., Williams, S.C.R., Irving, E. and Cash, D. 2020. Late changes in blood-brain barrier permeability in a rat tMCAO model of stroke detected by gadolinium-enhanced MRI. Neurological Research. 42 (10), pp. 844-852. https://doi.org/10.1080/01616412.2020.1786637 Article
2013
Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient Chilumuri, A., Ashioti, M., Nercessian, A.N. and Milton, N.G.N. 2013. Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient. Journal of Neurodegenerative Diseases. 2013 879710. https://doi.org/10.1155/2013/879710
2013
Sulforaphane alters cerebral leukocyte endothelial cell interactions post global ischaemia reperfusion Gillespie, S., Milton, N.G.N., Ashioti, M. and Gavins, F.N.E. 2013. Sulforaphane alters cerebral leukocyte endothelial cell interactions post global ischaemia reperfusion. FASEB Journal. 27, p. 687.18.
2012
Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro Milton, N.G.N., Chilumuri, A., Rocha-Ferreira, E., Nercessian, A.N. and Ashioti, M. 2012. Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro. ACS chemical neuroscience. 3 (9), pp. 706-719. https://doi.org/10.1021/cn300045d
2009
Neither in vivo MRI nor behavioural assessment indicatetherapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke Ashioti, M., Beech, J.S., Lowe, A.S., Bernanos, M., McCreary, A., Modo, M.M. and Williams, S.C.R. 2009. Neither in vivo MRI nor behavioural assessment indicatetherapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke. BMC Neuroscience. 10 (82). https://doi.org/10.1186/1471-2202-10-82
